135 related articles for article (PubMed ID: 27120117)
21. The aqueous extract of Glycyrrhiza inflata can upregulate unfolded protein response-mediated chaperones to reduce tau misfolding in cell models of Alzheimer's disease.
Chang KH; Chen IC; Lin HY; Chen HC; Lin CH; Lin TH; Weng YT; Chao CY; Wu YR; Lin JY; Lee-Chen GJ; Chen CM
Drug Des Devel Ther; 2016; 10():885-96. PubMed ID: 27013866
[TBL] [Abstract][Full Text] [Related]
22. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
[TBL] [Abstract][Full Text] [Related]
23. Convolvulus pluricaulis (Shankhapushpi) ameliorates human microtubule-associated protein tau (hMAPτ) induced neurotoxicity in Alzheimer's disease Drosophila model.
Kizhakke P A; Olakkaran S; Antony A; Tilagul K S; Hunasanahally P G
J Chem Neuroanat; 2019 Jan; 95():115-122. PubMed ID: 29051039
[TBL] [Abstract][Full Text] [Related]
24. C1 Inhibits Liquid-Liquid Phase Separation and Oligomerization of Tau and Protects Neuroblastoma Cells against Toxic Tau Oligomers.
Pradhan A; Mishra S; Surolia A; Panda D
ACS Chem Neurosci; 2021 Jun; 12(11):1989-2002. PubMed ID: 34008959
[TBL] [Abstract][Full Text] [Related]
25. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
Cente M; Filipcik P; Pevalova M; Novak M
Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434
[TBL] [Abstract][Full Text] [Related]
26. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
[TBL] [Abstract][Full Text] [Related]
27. Facilitated Tau Degradation by USP14 Aptamers via Enhanced Proteasome Activity.
Lee JH; Shin SK; Jiang Y; Choi WH; Hong C; Kim DE; Lee MJ
Sci Rep; 2015 Jun; 5():10757. PubMed ID: 26041011
[TBL] [Abstract][Full Text] [Related]
28. Development of a Tau-Targeted Drug Delivery System Using a Multifunctional Nanoscale Metal-Organic Framework for Alzheimer's Disease Therapy.
Zhao J; Yin F; Ji L; Wang C; Shi C; Liu X; Yang H; Wang X; Kong L
ACS Appl Mater Interfaces; 2020 Oct; 12(40):44447-44458. PubMed ID: 32897042
[TBL] [Abstract][Full Text] [Related]
29. Involvement of endoplasmic reticulum stress in tauopathy.
Sakagami Y; Kudo T; Tanimukai H; Kanayama D; Omi T; Horiguchi K; Okochi M; Imaizumi K; Takeda M
Biochem Biophys Res Commun; 2013 Jan; 430(2):500-4. PubMed ID: 23237806
[TBL] [Abstract][Full Text] [Related]
30. Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups.
Soeda Y; Yoshikawa M; Almeida OF; Sumioka A; Maeda S; Osada H; Kondoh Y; Saito A; Miyasaka T; Kimura T; Suzuki M; Koyama H; Yoshiike Y; Sugimoto H; Ihara Y; Takashima A
Nat Commun; 2015 Dec; 6():10216. PubMed ID: 26671725
[TBL] [Abstract][Full Text] [Related]
31. Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation
Shin SJ; Park YH; Jeon SG; Kim S; Nam Y; Oh SM; Lee YY; Moon M
Oxid Med Cell Longev; 2020; 2020():7829842. PubMed ID: 32685100
[TBL] [Abstract][Full Text] [Related]
32. Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide).
Gozes I; Iram T; Maryanovsky E; Arviv C; Rozenberg L; Schirer Y; Giladi E; Furman-Assaf S
J Alzheimers Dis; 2014; 40 Suppl 1():S23-36. PubMed ID: 24503616
[TBL] [Abstract][Full Text] [Related]
33. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
34. Intraneuronal accumulation of misfolded tau protein induces overexpression of Hsp27 in activated astrocytes.
Filipcik P; Cente M; Zilka N; Smolek T; Hanes J; Kucerak J; Opattova A; Kovacech B; Novak M
Biochim Biophys Acta; 2015 Jul; 1852(7):1219-29. PubMed ID: 25772164
[TBL] [Abstract][Full Text] [Related]
35. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease.
García-Font N; Hayour H; Belfaitah A; Pedraz J; Moraleda I; Iriepa I; Bouraiou A; Chioua M; Marco-Contelles J; Oset-Gasque MJ
Eur J Med Chem; 2016 Aug; 118():178-92. PubMed ID: 27128182
[TBL] [Abstract][Full Text] [Related]
36. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
Lewis J; Dickson DW
Acta Neuropathol; 2016 Jan; 131(1):27-48. PubMed ID: 26576562
[TBL] [Abstract][Full Text] [Related]
37. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341
[TBL] [Abstract][Full Text] [Related]
38. Shikonin impedes phase separation and aggregation of tau and protects SH-SY5Y cells from the toxic effects of tau oligomers.
Venkatramani A; Mukherjee S; Kumari A; Panda D
Int J Biol Macromol; 2022 Apr; 204():19-33. PubMed ID: 35120943
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of β-amyloid-induced tauopathy via activation of CK2α/SIRT1: targeting for cilostazol.
Lee HR; Shin HK; Park SY; Kim HY; Lee WS; Rhim BY; Hong KW; Kim CD
J Neurosci Res; 2014 Feb; 92(2):206-17. PubMed ID: 24254769
[TBL] [Abstract][Full Text] [Related]
40. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
Shiryaev N; Jouroukhin Y; Giladi E; Polyzoidou E; Grigoriadis NC; Rosenmann H; Gozes I
Neurobiol Dis; 2009 May; 34(2):381-8. PubMed ID: 19264130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
